ABSTRACT BACKGROUND: Major depressive disorder is increasingly recognized to involve functional deficits in both gammaaminobutyric acid (GABA)ergic and glutamatergic synaptic transmission. To elucidate the relationship between these phenotypes, we used GABA A receptor γ2 subunit heterozygous (γ2 1/2 ) mice, which we previously characterized as a model animal with construct, face, and predictive validity for major depressive disorder. METHODS: To assess possible consequences of GABAergic deficits on glutamatergic transmission, we quantitated the cell surface expression of N-methyl-D-aspartate (NMDA)-type and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid (AMPA)-type glutamate receptors and the function of synapses in the hippocampus and medial prefrontal cortex of γ2 1/2 mice. We also analyzed the effects of an acute dose of the experimental antidepressant ketamine on all these parameters in γ2 1/2 versus wild-type mice. RESULTS: Modest defects in GABAergic synaptic transmission of γ2 1/2 mice resulted in a strikingly prominent homeostatic-like reduction in the cell surface expression of NMDA-type and AMPA-type glutamate receptors, along with prominent functional impairment of glutamatergic synapses in the hippocampus and medial prefrontal cortex. A single subanesthetic dose of ketamine normalized glutamate receptor expression and synaptic function of γ2 1/2 mice to wildtype levels for a prolonged period, along with antidepressant-like behavioral consequences selectively in γ2 1/2 mice. The GABAergic synapses of γ2 1/2 mice were potentiated by ketamine in parallel but only in the medial prefrontal cortex. CONCLUSIONS: Depressive-like brain states that are caused by GABAergic deficits involve a homeostatic-like reduction of glutamatergic transmission that is reversible by an acute, subanesthetic dose of ketamine, along with regionally selective potentiation of GABAergic synapses. The data merge the GABAergic and glutamatergic deficit hypotheses of major depressive disorder.
Stable functioning of neural networks in the face of rapid changes in neural excitability is critically dependent on homeostatic self-tuning mechanisms that, on a slower time course, preserve the balance of excitation and inhibition and the average firing rates of neurons (28) . Homeostatic mechanisms have been studied most extensively in cultured neurons. Of particular interest in the context of the present study is a slow form of homeostatic synaptic plasticity whereby pharmacologically induced hyperexcitability of cultured neurons is compensated by global scaling down of glutamatergic synapses and scaling up of inhibitory synapses (29) (30) (31) (32) .
Mice rendered hemizygous for the γ2 subunit gene (Gabrg2) of GABA A Rs (γ2 1/2 mice) have been extensively characterized as a model with construct, face, and predictive validity for anxious MDD (15, 33) . These mice exhibit a modest impairment of GABAergic transmission characterized by loss of the γ2 subunit in 15% of GABA A Rs averaged across brain regions, with the most prominent reductions in neocortex and hippocampus (225% to 235%) (34) . The γ2-lacking GABA A Rs are functionally impaired as indicated by their reduced channel conductance (12 vs. 28 pS) and failure to accumulate at synapses (34) (35) (36) . Behaviorally, γ2
1/2 mice exhibit signs of heightened anxiety, despair, anhedonia, and constitutive stress axis activation, and all these phenotypes are normalized by long-term treatment with the antidepressant desipramine (34, 37, 38) . Cognitive alterations of γ2 1/2 mice in ambiguous cue conditioning tests mimic emotional pattern separation defects associated with MDD (34, 39, 40) . Moreover, a phospho-site mutation that increases the cell surface expression of γ2-GABA A Rs has antidepressant-like behavioral consequences (41) . Thus, the γ2 1/2 model lends support for a causative role of GABAergic deficits in the etiology of anxious MDD (15, 33) .
In this study, we explored the consequences of GABAergic deficits on glutamatergic synapses. We found that γ2 1/2 mice exhibit reduced cell surface expression and function of NMDARs and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs), along with reduced expression of the synaptic adhesion molecule neuroligin 1 (NL1) and defects in the density and function of glutamatergic synapses in the hippocampus and medial prefrontal cortex. Similar defects were observed in γ2 1/2 cultured neurons. Moreover, treatment of γ2 1/2 mice (or cultures) with a subanesthetic dose of ketamine resulted in lasting ($3 days) enhancement and normalization of glutamate receptor (GluR) expression and glutamatergic synapse function. Thus, depression-related brain states of γ2 1/2 mice involve a homeostatic-like reduction of glutamatergic transmission that can be normalized for a prolonged period by the rapidly acting antidepressant ketamine. Ketamine also potentiated the function of GABAergic synapses but only in anterior cingulate cortex (ACC). These data unite the GABAergic and glutamatergic deficit hypotheses of MDD, suggest that MDD may be caused by aberrant homeostatic plasticity, and provide novel insights into the synaptic mechanisms underlying antidepressant efficacy of ketamine.
METHODS AND MATERIALS
See the more detailed and complete version in Supplemental Methods and Materials.
Production and Husbandry of Mice
Two different GABA A R γ2 1/2 mouse lines were used as part of this study, with virtually identical germline deletions of exon 8 of the Gabrg2 locus. A first line of γ2 1/2 mice was maintained on a 129X1/SvJ background as previously described (34, 38, 42) . A second line was generated on the C57BL/6J background by mating γ2 f/f mice (43) with an oocyte-specific Cre line followed by outcrossing of the Cre transgene. Mice used for experimentation were littermates produced by crossing of γ2 1/2 mice and wild-type (WT) mice. The 129X1/SvJ line was used for preparation and analyses of cortical cultures as well as biochemical and electrophysiologic analyses of brain slices. The C57BL/6J line was used for biochemical and behavioral experimentation involving ketamine treatment.
Drug Treatments
For treatment of cultures, the drugs were diluted or dissolved in culture media to the following final concentrations: ketamine, 10 μmol/L (Ketaject; Phoenix Pharmaceutical, Inc., St. Joseph, MO); D-(-)-2-amino-5-phosphonopentanoic acid (D-APV), 100 μmol/L (Sigma-Aldrich, St. Louis, MO); bicuculline (BIC), 20 μmol/L (R&D Systems, Minneapolis, MN); and Ro 25-6981, 10 μmol/L (Sigma-Aldrich). For treatment of mice (8-9 weeks old), ketamine (Ketaject diluted to 1 mg/mL in 0.9% saline) was administered at 10 mg/kg (biochemical and electrophysiologic analyses) or 3 mg/kg (behavioral analyses) (intraperitoneal injection [i.p.]) as previously described (26, 44) .
Cell Surface Biotinylation
Cortical cultures from γ2 1/2 and WT mice were generated from embryonic day 14-15 embryos (129X1/SvJ line) and subjected to cell surface biotinylation at 21 days in vitro and purification using NeutrAvidin agarose beads (Thermo Scientific, Rockford, IL) as described previously (45) . For biotinylation of brain slices, we adapted the protocol of Terunuma et al. (46) . The biotinylated proteins were quantitated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis/western blot using an Odyssey CLx infrared imager (LI-COR Biosciences, Lincoln, NE). Amounts of cell surface biotinylated proteins were normalized to amounts of β-tubulin in total extracts quantitated on parallel gels.
Immunofluorescent Staining of Cortical Cultures
Immunofluorescent staining of neurons employed glia-free cortical cultures prepared from embryonic day 14-15 embryos as previously described (47) . The cells were fixed, permeabilized, and stained at 21 days in vitro as described (47) using rabbit anti-MAP2 (1:1000, Ab5622; EMD Millipore Corp., Billerica, MA), guinea pig anti-VGluT1 (1:500, LV1439669; EMD Millipore Corp.), mouse anti-PSD95 (1:1500, No. 28879; EMD Millipore Corp.), mouse anti-gephyrin (1:500, No. 147111; Synaptic Systems GmbH, Goettingen, Germany), and rabbit anti-vesicular GABA transporter (1:1000, No. 131002; Synaptic Systems GmbH). Synaptic immunoreactivities were developed and quantified as described (47) .
Electrophysiology
Coronal slices (350 μm) containing the dorsal hippocampus or ACC were prepared using a vibratome (Leica VT1200S; Leica Biosystems, Inc., Buffalo Grove, IL) from 7-to 13-week-old Homeostatic Regulation of a Depressive-like Brain State 129X1/SvJ mice (of either sex) in a solution containing 210 mmol/L sucrose, 7 mmol/L D-glucose, 25 mmol/L sodium bicarbonate, 1.25 mmol/L monosodium phosphate, 2.5 mmol/L potassium chloride, 1.3 mmol/L sodium ascorbate, 3 mmol/L sodium pyruvate, 0.5 mmol/L calcium chloride, and 7 mmol/L magnesium chloride, saturated with 95% oxygen/5% carbon dioxide. During recordings, slices were perfused with 50 mmol/L sucrose, 119 mmol/L sodium chloride, 26.2 mmol/L sodium bicarbonate, 11 mmol/L glucose, 2.5 mmol/L potassium chloride, 1 mmol/L monosodium phosphate, 2.5 mmol/L calcium chloride, and 1.3 mmol/L magnesium chloride, saturated with 95% oxygen/5% carbon dioxide, and 0.5 
Statistics
Statistical comparisons were performed using two-tailed Student t tests or analysis of variance (ANOVA) followed by post hoc analyses as detailed in the text and figure legends.
RESULTS

GABAergic Deficits of γ2-Deficient Neurons Result in Homeostatic Downregulation of GluRs
Chronic blockade of GABA A Rs in cultured neurons with BIC results in homeostatic downregulation of NMDA and AMPAR function (Supplemental Figure S1A) (29) . Therefore, to begin to test whether similar changes in GluR expression might occur in γ2 1/2 mice, we began our analyses in γ2 2/2 and WT cultured cortical neurons (21 days in vitro). As a proxy for NMDARs, we quantitated the cell surface expression of the obligatory subunit GluN1 as well as the GluN2B subunit, which is part of an (48) and antidepressant effects of ketamine (49) . In addition, we quantitated the cell surface expression of NL1, a postsynaptic cell adhesion molecule that controls the accumulation of NMDARs at synapses (50) . Lastly, we surveyed the expression of AMPARs using antibodies for GluA2/3 subunits. Using cell surface biotinylation assays, we found that the plasma membrane accumulation of all four proteins was drastically reduced in γ2 2/2 compared with WT cultures ( Figure 1A ). The cell surface expression of the same four proteins also was reduced in γ2 1/2 compared with WT cultures ( Figure 1B) , with effect sizes comparable to those in γ2 2/2 versus WT cultures ( Figure 1A ) and BIC-treated WT cultures (Supplemental Figure S1A ). Total expression of GluN1 and GluA2/3 was unaffected in γ2 2/2 compared with WT cultures and BIC-treated WT cultures, suggesting that the changes at the cell surface were due to impaired trafficking of receptors (Supplemental Figure S1A , B). Therefore, a modest defect in GABA A R function in γ2 1/2 cultures (36,51) leads to a profound downregulation of GluRs that is reminiscent of homeostatic scaling down of synapses induced by complete pharmacologic blockade of GABA A Rs.
Ketamine-Induced Reversal of GluR Deficits
We hypothesized that downregulation of GluRs was related to the depressive-like brain state of γ2 1/2 mice (37,38) and that it should be reversible by antidepressant concentrations of ketamine. We treated γ2 1/2 cultures with ketamine (10 mmol/L) for variable amounts of time and found that GluN1 cell surface expression was increased significantly within 3 hours of treatment ( Figure 1C ). Cell surface AMPARs were increased similarly but with about a 1.5-hour delay. Ketamine also increased cell surface expression of NL1, with a time course similar to that of GluN1 (Supplemental Figure S2A) , which is consistent with a role of NL1 in cell surface trafficking of NMDARs (50) . The effect of 10 mmol/L ketamine on cell surface GluRs of γ2 1/2 cultures was reproduced by the GluN2B specific antagonist Ro 25-6981 (10 mmol/L) and the competitive NMDAR antagonist APV (100 mmol/L) (Supplemental Figure S2B , C).
Glutamatergic Synapse Density Is Reduced by GABA A R Deficits and Normalized by Ketamine Treatment
To address whether GABA A R deficits and ketamine impact the density of glutamatergic synapses, we immunostained cultured cortical neurons for the presynaptic and postsynaptic markers vGluT1 and PSD95. The density of punctate immunoreactivity for both markers and their colocalization along dendrites was reduced in γ2 1/2 compared with WT neurons (Figure 2A -E). Treatment of γ2 1/2 cultures with ketamine (10 mmol/L, 6 hours) normalized the expression and colocalization of vGluT1 and PSD95 to WT levels ( Figure 2A -E), whereas the size of immunoreactive puncta was unaffected by genotype and drug treatment ( Figure 2F ). Thus, GABA A R deficit-induced reductions in GluR and NL1 cell surface expression and their normalization by ketamine correlate with changes in the number of synapses, rather than a change in protein accumulation at individual synapses.
GABA A R γ2
1/-Model Shows Increased Sensitivity to Anxiolytic-like and Antidepressant-like Behavioral Effects of Ketamine
Assuming that ketamine-induced surface expression of GluRs was related to its antidepressant activity, we predicted that ketamine exerts increased antidepressant behavioral effects in γ2 1/2 compared with WT mice. However, preliminary experiments designed to address behavioral effects of ketamine revealed, inexplicably, that γ2 1/2 and WT mice maintained on a 129X1/SvJ strain background failed to show antidepressantlike behavioral responses to ketamine (not shown), reminiscent of other mouse strains that are insensitive to ketamine (52, 53) . Therefore, we re-derived γ2 1/2 mice on a C57BL/6J genetic background, which has been widely used for studies of ketamine. The anxiety-like phenotype of γ2 1/2 mice in the elevated plus maze was fully normalized to WT levels 8 hours after a single dose of ketamine (3 mg/kg, i.p.), without effects in WT mice ( Figure 3A ). Moreover, ketamine had antidepressant-like consequences in the forced swim test selectively in γ2 1/2 mice but not WT mice ( Figure 3B ). Thus, γ2
1/2 mice are more sensitive than WT mice to the anxiolyticlike and antidepressant-like behavioral effects of ketamine.
GABA A R Deficits of γ2 1/2 Mice Result in Downregulation of GluRs In Vivo
To begin to assess the fate of glutamatergic synapses in vivo, we quantified the cell surface expression of GluRs in acute brain slices of the hippocampus and the ACC/prelimbic cortex (PLC), which are among the brain areas with the greatest GABA A R deficit in γ2 1/2 mice (34) and essential for antidepressant drug-induced behavioral effects in rodents (54, 55) . The cell surface AMPARs and NMDARs were drastically reduced in γ2 1/2 mice compared with WT mice in both hippocampus and ACC/PLC ( Figure 4A ).
Subanesthetic Dose of Ketamine Given to γ2
1/2 Mice Normalizes NMDAR Cell Surface Expression In Vivo
To examine whether ketamine affected expression of GluR in vivo, we treated γ2 1/2 mice with ketamine (C57BL/6J, strain, 10 mg/kg, i.p.) and 24 hours later harvested hippocampal and ACC/PLC brain slices for quantification of cell surface proteins. Ketamine treatment of γ2 1/2 mice resulted in significant upregulation and normalization of cell surface NMDARs in both hippocampus and ACC/PLC ( Figure 4B) . Expression of the GluN2B subunit appeared increased to similar levels as GluN1, although the effect was more variable and significant only in hippocampus. Total expression of NMDARs remained unaltered, indicating that ketamine acted posttranslationally to normalize impaired cell surface accumulation of NMDARs. In contrast to NMDARs, cell surface AMPARs of γ2 1/2 mice were upregulated by ketamine only in hippocampus and were unaffected in ACC/PLC (however, see below for effects of ketamine at 3 days after treatment; Figure 4C ). Moreover, this drug effect in hippocampus involved increased total expression of AMPARs, rather than merely a change in cell surface accumulation ( Figure 4B ). Comparing the hippocampal cell surface expression of GluRs of ketaminetreated γ2 1/2 mice and drug-naïve WT mice ( Figure 4A , B, data Homeostatic Regulation of a Depressive-like Brain State normalized to values of drug-naïve γ2 1/2 mice) indicated that ketamine fully restored the expression of GluRs from γ2 1/2 to WT levels (γ2 1/2 plus ketamine vs. WT, p 5 not significant, n 5 9-12, for both GluN1 and GluA2/3, ANOVA, Tukey test).
Given the lasting therapeutic effects of ketamine in patients (23), we further assessed whether the drug effects on GluR expression seen 1 day after treatment remained measurable 3 days after treatment. In hippocampus, both GluN1 and GluA2/3 remained significantly elevated compared with vehicle-treated γ2 1/2 mice 3 days after treatment ( Figure 4C ). By contrast, in prefrontal cortex, the effects of ketamine on GluN1 were no longer detectable. Instead, there was a strong trend for upregulation of GluA2/3 that was not observed 1 day after treatment (Figure 4B, C) . Thus, a subanesthetic dose of ketamine can reverse homeostatic downregulation of glutamatergic synapses in the hippocampus induced by impaired GABAergic transmission for at least 3 days after treatment. Moreover, ketamine-induced augmentation of AMPAR expression in prefrontal cortex may be delayed relative to that of NMDAR and slower than in hippocampus.
Ketamine had no effect on GluR cell surface expression in WT mice, independent of brain region analyzed (1-day treatment) ( Figure 4D ) and consistent with the selective behavioral effects of ketamine in γ2 1/2 but not WT mice described in Figure 3 . Downregulation of GluRs was evident in γ2 1/2 mice of both genetic backgrounds, C57BL/6J ( Figure 4A ) and 129X1/SvJ (Supplemental Figure S1C) , suggesting that differential behavioral sensitivity of the two genetic backgrounds to the effects of ketamine was due to strain differences acting downstream of altered GluR expression.
GABA A R Deficits Reduce the Number of Functional Glutamatergic Synapses In Vivo and This Defect Is Reversed by a Single Dose of Ketamine
We next assessed functional defects in glutamatergic transmission using voltage clamp recordings of CA1 pyramidal cells in hippocampal slices. The frequency of spontaneous EPSCs (sEPSCs) was drastically reduced in γ2 1/2 compared with WT cells, whereas the amplitude was unaffected (Figure 5A-C) . Ketamine administered to mice 24 hours before recordings normalized the sEPSC frequency of γ2 1/2 mice to WT levels and had no effect in WT mice ( Figure 5C ). Neither ketamine nor genotype affected the amplitude of sEPSCs ( Figure 5B ). Consistent with results obtained by immunostaining of cultures (Figure 2 ), these findings suggest that GABA A R deficits and ketamine affect glutamatergic transmission through a change in the number of functional synapses, rather than through changes in the abundance of AMPARs at synapses. Chronic stress has been shown to preferentially affect temporoammonic (TA) synapses onto CA1 pyramidal neurons rather than Schaffer collateral (SC) synapses (56) . To further characterize the synaptic deficits of γ2 1/2 CA1 pyramidal cells, we recorded AMPAR and NMDAR EPSCs evoked by selective stimulation of either the SC or the TA pathway. The AMPAR EPSC amplitudes were significantly reduced in γ2 1/2 compared with WT slices, with a more pronounced effect at TA synapses ( Figure 5D-G) . Moreover, ketamine treatment of γ2 1/2 mice normalized SC-evoked AMPAR EPSCs to WT levels, without corresponding effects in WT mice ( Figure 5E ). At TA synapses, ketamine potentiated the AMPAR responses, with greater effects in γ2 1/2 than WT mice (WT ketamine as % WT vehicle vs. γ2 1/2 ketamine as % γ2 and TA-CA1 synapses of γ2 1/2 mice were impaired at baseline and restored to WT levels by ketamine pretreatment ( Figure 5H-K) .
To further examine the idea that the reduced sEPSC frequency of γ2 1/2 neurons reflected a reduction in the density of synapses ( Figure 5A, B) , we assessed the synaptic release probability by measuring paired pulse ratios from SC and TA path-stimulated pyramidal cells (Supplemental Figure S3) . The paired pulse ratios were unaffected by genotype for both types of synapses and increased by ketamine selectively at TA-CA1 synapses. Thus, genotype-dependent and treatment-dependent alterations of glutamatergic transmission primarily reflect changes in synapse number rather than release probability. Furthermore, neither genotype nor ketamine treatment affected the rectification of AMPAR responses evoked by SC or TA pathway stimulation (Supplemental Figure S4) , indicating that the calcium permeability of AMPARs does not play a significant role in the forms of plasticity examined here. 
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Ketamine Enhances GABAergic Synaptic Inhibition in Frontal Cortex
Ketamine has potent seizure-suppressing effects in animal models of epilepsy and in patients (57) (58) (59) . Therefore, we wondered whether ketamine-induced potentiation of glutamatergic transmission was accompanied by an increase in GABAergic inhibition. Comparison of γ2 1/2 and WT cultured cortical neurons by immunofluorescent staining for the presynaptic and postsynaptic markers vesicular GABA transporter and gephyrin revealed a significant reduction in the size and density of punctate gephyrin immunoreactivity in γ2 1/2 versus WT cultures, with both of these defects fully reversed WT, p , .05, n = 6-7) and trended lower in ACC/PLC (p = .15, n = 6-7).
(B) In γ2 1/2 mice analyzed 24 hours after an acute dose of ketamine (10 mg/kg, i.p.), the cell surface expression of N-methyl-D-aspartate receptors (NMDARs) and alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionic acid receptors (AMPARs) in hippocampus was increased compared with vehicle-treated (Veh) γ2 1/2 control mice (p , .05, n = 7-11, for GluN1, GluN2B, and GluA2/ 3 comparisons) to levels comparable to WT mice in (A) (γ2 1/2 plus ketamine vs. WT, p = not significant, n = 9-12). In ACC/PLC, ketamine treatment of γ2 1/2 mice resulted in increased expression of NMDARs (γ2 1/2 ketamine vs. vehicle, GluN1, p , .05) but not AMPARs (GluA2/3, p = not significant, n = 8-9 for both comparisons). Cell surface GluN2B levels trended in the same direction as GluN1, but the effect was not significant (p = .12, n = 3). (C) In hippocampus of γ2 1/2 mice analyzed 3 days after ketamine treatment, the cell surface expression of NMDA and AMPARs remained increased compared with control mice (p , .05, n = 10-12, for both GluN1 and GluA2/3). By contrast, in ACC/PLC, the GluN1 cell surface level had returned to baseline (p = not significant, n = 8-9), but the GluA2/3 cell surface expression showed a strong trend of an increase (p = .08, n = 6/group) that was not yet evident at 1 day after treatment (B). (D) In WT mice analyzed 24 hours after ketamine treatment, the expression of NMDA and AMPARs was unchanged compared with vehicle controls in hippocampus and ACC/PLC (WT vehicle vs. ketamine, p = not significant, n = 5-6, for all four comparisons). Data are from mice maintained on a C57BL/6J background. The genotype differences were reproduced with 129X1/SvJ mice (Supplemental Figure S1C) . Data represent means 6 SE. *p , .05, ***p , .001, t tests. Tub, tubulin.
Homeostatic Regulation of a Depressive-like Brain State
Biological Psychiatry September 15, 2016; 80:457-468 www.sobp.org/journalafter 6 hours of treatment of γ2 1/2 cultures with 10 μmol/L ketamine ( Figure 6A-G) . A modest but significant increase in the density of gephyrin puncta was also observed in WT cultures ( Figure 6F ). Vesicular GABA transporter staining of γ2 1/2 cultures was increased by ketamine in parallel with gephyrin ( Figure 6G ), suggesting that ketamine potentiated the postsynaptic apparatus, while increasing the number of GABAergic synapses in γ2 1/2 cultures. Consistent with this interpretation, the colocalization of vesicular GABA transporter and gephyrin was unaffected by genotype or ketamine Homeostatic Regulation of a Depressive-like Brain State treatment ( Figure 6H ). As expected, the amplitude of mIPSCs recorded from CA1 and L2/3 ACC pyramidal cells of γ2
brain slices was reduced compared with WT, whereas the frequency was unaltered ( Figure 6I-L) . Therefore, γ2
neurons display a defect in GABAergic inhibition that is not compensated for by any process resembling homeostatic scaling up of inhibitory synaptic strength seen after prolonged treatment of cultured neurons with BIC. We found that ketamine had no effect on mIPSCs recorded from CA1 neurons of γ2 1/2 mice ( Figure 6I, J) . However, ketamine fully restored Figure 6K, L) . Ketamine did not affect the amplitude or frequency of mIPSCs of WT mice, consistent with our other observations that showed that ketamine effects on GluR expression, synapse density, and emotional behavior were enhanced or specific for γ2 1/2 mice representing the pathologic condition. Glutamatergic synapses of L2/3 pyramidal cells were downregulated in γ2 1/2 mice and restored by ketamine administration to WT levels (Supplemental Figure  S5A, B) , similar to results obtained with CA1 pyramidal cells. Thus, GABAergic synapses in ACC of γ2 1/2 mice are potentiated by ketamine both presynaptically and postsynaptically, in concert with restoration of glutamatergic synapses and antidepressant behavioral effects.
DISCUSSION
We have shown in the present study that the depressionrelated brain state of γ2 1/2 mice induced by GABAergic deficit involves a homeostatic-like reduction of glutamatergic transmission. A modest reduction in GABAergic transmission in γ2 1/2 mice, consisting of 20% reduction in the mIPSC amplitude of principal cells, leads to a robust 30%-50% reduction in cell surface NMDA and AMPARs and 50% reduction in sEPSC frequency. Hyperexcitability of cultured neurons induced by chronic BIC treatment is known to result in homeostatic scaling down of glutamatergic synapses in concert with scaling up of inhibitory synapses (29, 30) and increased expression of postsynaptic GABA A Rs (31) . Compared with complete (but transient) blockade of GABA A Rs by BIC treatment of cultures, γ2 1/2 mice and cultures display only a modest reduction of GABA A R function. However, in contrast to in BIC-treated cultures, inhibitory synapses are not strengthened in γ2 1/2 mice, possibly as a result of the limiting amounts of γ2-GABA A Rs. It is conceivable that homeostatic mechanisms of γ2 1/2 mice that serve to restore the balance of excitation and inhibition ended up exacerbating downregulation of glutamatergic transmission. Similar homeostatic mechanisms are likely to operate under conditions of chronic or repeated stress, which are used to model depression in rodents, involve downregulation of AMPARs and NMDARs (60) , result in increased behavioral responsiveness to ketamine (61) , and hence involve changes in glutamatergic transmission comparable to changes observed in the γ2 1/2 model. Chronic stress also increases the chloride reversal potential, which renders GABAergic inhibition ineffective or excitatory (62) (63) (64) . Thus, stress-induced downregulation of GluRs may be a consequence of excessive excitatory drive and impaired upregulation of inhibition analogous to mechanisms observed in the γ2 1/2 model. Our findings merge the GABAergic (15,16) and glutamatergic (21,60) deficit hypotheses of MDD and provide a novel mechanism for how these two neurotransmitter systems interact in the etiopathology of MDD.
Second, we showed that the GABAergic deficit-induced adaptations of glutamatergic synapses in γ2 1/2 mice are reversed by an acute subanesthetic dose of ketamine. Normalization of GluR expression and synapse density was also observed in γ2 1/2 cultures in the continuous presence of ketamine or APV or Ro 25-6981, whereas WT cultures were unaffected by ketamine or Ro 25-6981. These observations suggest that downregulation of NMDARs in γ2 1/2 cultures and mice involves excessive or untimely activation of NMDARs, most likely as a result of chronically increased release of glutamate. Evidence indicates that the initial effect of a subanesthetic dose of ketamine is to block a subpopulation of NMDARs that are active at rest (44), followed by increased expression of AMPARs (26) . Our data extend these findings and show that initial antagonistic effects of ketamine on NMDARs are followed by restoration of previously compromised expression and function of postsynaptic NMDARs, in addition to increased expression and function of AMPARs. Moreover, the effects of ketamine were greatly enhanced or specific for γ2 1/2 mice compared with WT mice (i.e., under conditions representing the pathologic condition).
Third, we showed that in concert with enhanced glutamatergic transmission, ketamine potentiates the presynaptic and postsynaptic function of GABAergic inhibitory synapses of L2/3 ACC pyramidal cells of γ2 1/2 mice. This drug effect occurred despite the impairment of inhibitory synapses that is evident in untreated γ2 1/2 mice. An enduring potentiation of synaptic inhibition is consistent with the known seizuresuppressing effects of ketamine (57) (58) (59) .
Fourth, downregulation of cell surface NMDARs in γ2 1/2 neurons and its reversal by ketamine were paralleled by corresponding changes in the cell surface expression of NL1, a synaptogenic cell adhesion protein that contributes to activity-dependent balancing of glutamatergic and GABAergic synaptic transmission (65) and controls the synaptic accumulation of NMDARs (50) . Thus, aberrant trafficking of NL1 may play a key role in maladaptations observed in γ2 1/2 mice and their reversal by ketamine.
In conclusion, GABA A R deficit-induced downregulation of cell surface GluRs is reminiscent of chronic stress-induced downregulation of AMPARs and NMDARs in medial prefrontal cortex (66) (67) (68) and downregulation of AMPARs selectively at TA-CA1 synapses (56, 69) . Similar to selective stress-induced impairment of TA-CA1 synapses, the functional deficit in γ2 1/2 mice was greater at TA-CA1 than at SC-CA1 synapses (TA-CA1 γ2 1/2 as % WT vs. SC-CA1 γ2 1/2 as % WT [F 1,120 = 5.714, p = .0184, two-way ANOVA]) ( Figure 5E vs. G). The TA-CA1 synapses map to distal apical dendrites of CA1 pyramidal cells that are targets of somatostatin-positive oriens-lacunosum moleculare cells (70) . Somatostatin interneurons are highly sensitive to stress and functionally impaired in patients with MDD (71). Thus, endogenous or stress-induced GABAergic deficits may be key for stress-induced downregulation of CA1 pyramidal neuron glutamatergic synapses. Elucidating the signaling pathways underlying homeostatic plasticity of GABAergic and glutamatergic synaptic transmission should lead to novel approaches for the treatment of MDD. Homeostatic Regulation of a Depressive-like Brain State
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